64 related articles for article (PubMed ID: 14204551)
1. Management of primary aldosteronism: evaluation of potassium and sodium balance, technic of adrenalectomy and operative results in 24 cases.
Silen W; Biglieri EG; Slaton P; Galante M
Ann Surg; 1966 Oct; 164(4):600-10. PubMed ID: 5924782
[No Abstract] [Full Text] [Related]
2. [SECONDARY HYPERALDOSTERONISM. PHYSIOPATHOLOGIC, CLINICAL AND THERAPEUTIC CONSIDERATIONS].
DEMARTINIS C; FONZO D
Clin Ter; 1963 Oct; 27():51-72. PubMed ID: 14097444
[No Abstract] [Full Text] [Related]
3. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CARDIAC EDEMA].
KONONIACHENKO VA; GERASIMOVA EN
Kardiologiia; 1964; 4():76-86. PubMed ID: 14184139
[No Abstract] [Full Text] [Related]
4. ALDOSTERONE IN CLINICAL MEDICINE.
BIGLIERI EG; SLATON PE
Calif Med; 1964 Sep; 101(3):191-5. PubMed ID: 14204551
[No Abstract] [Full Text] [Related]
5. CLINICAL ASSESSMENT OF DIURETICS.
SHETH UK; VAIDYA A; KHOKHANI RC; SHAH MJ
Indian J Med Sci; 1964 Jul; 18():379-86. PubMed ID: 14176221
[No Abstract] [Full Text] [Related]
6. CIRRHOSIS--FLUID RETENTION AND ASCITES.
VOLWILER W
Mod Treat; 1964 Mar; 1():451-61. PubMed ID: 14159599
[No Abstract] [Full Text] [Related]
7. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
HOFFMEISTER W
Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
[No Abstract] [Full Text] [Related]
8. [ALDOSTERONE AND SPIROLACTONES IN THE CLINICAL TREATMENT OF INTERNAL DISEASES (REVIEW OF THE LITERATURE AND ANALYSIS OF PERSONAL CASES)].
POLIANTSEVA LR; ERMOLENKO VM
Sov Med; 1963 Dec; 27():42-51. PubMed ID: 14150357
[No Abstract] [Full Text] [Related]
9. MERCURIAL DIURETICS AND EDEMA.
GORLIN R
JAMA; 1965 May; 192():468-70. PubMed ID: 14284848
[No Abstract] [Full Text] [Related]
10. The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension.
LARAGH JH
JAMA; 1960 Sep; 174():293-5. PubMed ID: 14414164
[No Abstract] [Full Text] [Related]
11. Aldosterone secretion and primary and malignant hypertension.
LARAGH JH; ULICK S; JANUSZEWICZ V; DEMING QB; KELLY WG; LIEBERMAN S
J Clin Invest; 1960 Jul; 39(7):1091-106. PubMed ID: 14414161
[No Abstract] [Full Text] [Related]
12. Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man.
LARAGH JH; ANGERS M; KELLY WG; LIEBERMAN S
JAMA; 1960 Sep; 174():234-40. PubMed ID: 14414160
[No Abstract] [Full Text] [Related]
13. Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone.
HICKLER RB; THOMPSON GR; FOX LM; HAMLIN JT
N Engl J Med; 1959 Oct; 261():788-91. PubMed ID: 14401690
[No Abstract] [Full Text] [Related]
14. Isolation of crystalline aldosterone from the urine of a nephrotic patient.
LUETSCHER JA; NEHER R; WETTSTEIN A
Experientia; 1954 Nov; 10(11):456-8. PubMed ID: 14353060
[No Abstract] [Full Text] [Related]
15. PRIMARY ALDOSTERONISM WITH MALIGNANT HYPERTENSION.
KAPLAN NM
N Engl J Med; 1963 Dec; 269():1282-6. PubMed ID: 14065472
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
